Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 25% ± 7% | |
| epithelial cell | 4 studies | 22% ± 4% | |
| hepatocyte | 4 studies | 28% ± 9% | |
| oligodendrocyte precursor cell | 4 studies | 28% ± 8% | |
| brush cell | 4 studies | 34% ± 11% | |
| intestinal crypt stem cell | 3 studies | 21% ± 4% | |
| goblet cell | 3 studies | 25% ± 2% |
Insufficient scRNA-seq data for expression of CHDH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 5701.35 | 226 / 226 | 99% | 30.78 | 400 / 406 |
| brain | 100% | 2118.75 | 2633 / 2642 | 96% | 20.06 | 680 / 705 |
| kidney | 100% | 6587.01 | 89 / 89 | 90% | 29.38 | 810 / 901 |
| prostate | 91% | 1882.40 | 223 / 245 | 98% | 25.70 | 492 / 502 |
| pancreas | 100% | 2951.15 | 328 / 328 | 87% | 12.33 | 154 / 178 |
| stomach | 79% | 1563.69 | 284 / 359 | 94% | 24.56 | 270 / 286 |
| breast | 65% | 2043.90 | 300 / 459 | 93% | 19.39 | 1037 / 1118 |
| intestine | 56% | 1462.30 | 544 / 966 | 96% | 27.12 | 505 / 527 |
| lung | 91% | 686.25 | 526 / 578 | 48% | 5.58 | 560 / 1155 |
| thymus | 96% | 815.80 | 624 / 653 | 42% | 2.63 | 254 / 605 |
| uterus | 78% | 747.17 | 132 / 170 | 40% | 3.98 | 182 / 459 |
| ovary | 70% | 311.24 | 126 / 180 | 40% | 3.40 | 173 / 430 |
| adrenal gland | 93% | 796.72 | 239 / 258 | 2% | 0.24 | 5 / 230 |
| muscle | 92% | 580.02 | 735 / 803 | 0% | 0 | 0 / 0 |
| esophagus | 20% | 92.71 | 282 / 1445 | 54% | 10.10 | 98 / 183 |
| skin | 60% | 456.07 | 1077 / 1809 | 8% | 0.72 | 36 / 472 |
| heart | 62% | 394.26 | 537 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 12.49 | 17 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 4.34 | 21 / 45 |
| bladder | 0% | 0 | 0 / 21 | 40% | 8.12 | 200 / 504 |
| peripheral blood | 19% | 578.59 | 176 / 929 | 0% | 0 | 0 / 0 |
| adipose | 15% | 67.01 | 178 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 9% | 36.09 | 120 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 5% | 24.12 | 13 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.24 | 3 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042426 | Biological process | choline catabolic process |
| GO_0019285 | Biological process | glycine betaine biosynthetic process from choline |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
| GO_0008812 | Molecular function | choline dehydrogenase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CHDH |
| Protein name | Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1) Choline dehydrogenase |
| Synonyms | |
| Description | |
| Accessions | C9JYW4 C9J7D8 ENST00000467802.1 Q8NE62 ENST00000481668.5 ENST00000315251.11 |
